With genetic test spending under the microscope, CMS is asking labs to help shape future anti-fraud rules—before formal proposals are…
Read More
Jeito Capital’s Second Fund Closes Above Target, Bolstering European Biopharma Investment to Over €1.6 Billion
Global independent private equity fund Jeito Capital has achieved a significant milestone in European biopharma investment with the successful closure…
Read More
New fossils from the Ediacaran Period reveal animal groups are older than previously understood
The discovery of remarkably preserved fossils in Yunnan, China, is rewriting our understanding of early animal evolution, pushing back the…
Read More
The Unveiling of Life’s Trajectory: Midlife Behaviors as Predictors of Longevity
A groundbreaking study, supported by the Knight Initiative for Brain Resilience at Stanford’s Wu Tsai Neurosciences Institute, has revealed a…
Read More
TWiV 1286: Clinical Update with Dr. Daniel Griffin
In a recent episode of "This Week in Virology" (TWiV) podcast, Dr. Daniel Griffin, a prominent infectious disease clinician, and…
Read More
Glioblastoma Research Reveals Skull Bone Erosion and Immune System Manipulation by Aggressive Brain Tumors
In a landmark study published on October 3 in the journal Nature Neuroscience, researchers from the Montefiore Einstein Comprehensive Cancer…
Read More
Lilly Ascends to Pharma’s Top Revenue Spot Amidst Landmark Oral GLP-1 Approval, Yet Wall Street Remains Unconvinced
Eli Lilly and Company has officially claimed the top spot among global pharmaceutical companies by revenue, a monumental achievement underscored…
Read More
Gut Bacteria Identified as Key Driver in the Progression of ALS and Frontotemporal Dementia
Researchers at Case Western Reserve University have unveiled a groundbreaking study that identifies a significant link between gut microbiota and…
Read More
Doherty Institute researchers unveil an assay that identifies four STIs and antibiotic resistance in under an hour with up to 100% precision.
Researchers at the prestigious Peter Doherty Institute for Infection and Immunity in Melbourne, Australia, have announced a groundbreaking advancement in…
Read More
US Government Invests Heavily in Antibiotic Manufacturing to Combat Antimicrobial Resistance
The United States government, through the Biomedical Advanced Research and Development Authority (BARDA), has committed up to $482 million to…
Read More
